Human papillomavirus and control of cervical cancer in India

References

• Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin.55(2), 74–108 (2005).
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R. Overview of cervical cancer in the developing world. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int. J. Gynaecol. Obstet.95(Suppl. 1), S205–S210 (2006).
   Google Scholar
• Sankaranarayanan R, Ferlay J. Worldwide burden of gynaecological cancer: the size of the problem. Best Pract. Res. Clin. Obstet. Gynaecol.20(2), 207–225 (2006).
   PubMed Web of Science ®Google Scholar
• Franceschi S. The IARC commitment to cancer prevention: the example of papillomavirus and cervical cancer. Recent Results Cancer Res.166, 277–297 (2005).
   PubMedGoogle Scholar
• Cancer Incidence in Five Continents (Volume VIII). Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (Eds). International Agency for Research on Cancer, Lyon, France (2002).
   Google Scholar
• Human Papillomaviruses. IARC (Ed.) International Agency for Research on Cancer, Lyon, France (2005).
   Google Scholar
• Das BC, Gopalkrishna V, Hedau S, Katiyar S. Cancer of the uterine cervix and human papillomavirus infection. Curr. Sci.78(1), 52–63 (2000).
   Google Scholar
• Pagliusi S. Vaccines against human papillomavirus. WHO, Geneva, Switzerland (2001).
   Google Scholar
• Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect. Dis.6(1), 21–31 (2006).
   PubMed Web of Science ®Google Scholar
• Stanley M. Chapter 17: genital human papillomavirus infections – current and prospective therapies. J. Natl Cancer Inst. Monogr.31, 117–124 (2003).
   PubMedGoogle Scholar
• Munger K, Phelps WC, Bubb V, Howley PM, Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol.63(10), 4417–4421 (1989).
   PubMed Web of Science ®Google Scholar
• Noller KL. Incident and demographic trends in cervical neoplasia. Am. J. Obstet. Gynecol.175(4 Pt 2), 1088–1090 (1996).
   PubMed Web of Science ®Google Scholar
• zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer2(5), 342–350 (2002).
   PubMed Web of Science ®Google Scholar
• Jo H, Kim W. Implications of HPV infection in uterine cervical cancer. Cancer Ther.3, 419–434 (2005).
   Google Scholar
• Ley C, Bauer HM, Reingold A et al. Determinants of genital human papillomavirus infection in young women. J. Natl Cancer Inst.83(14), 997–1003 (1991).
   PubMed Web of Science ®Google Scholar
• Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med.338(7), 423–428 (1998).
   PubMed Web of Science ®Google Scholar
• Richardson H, Kelsall G, Tellier P et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol. Biomarkers Prev.12(6), 485–490 (2003).
   PubMed Web of Science ®Google Scholar
• Agarwal SK, Chatterji A, Bhambhani S, Sharma BK. Immunohistochemical co-expression of human papillomavirus type 16/18 transforming (E6) oncoprotein and p53 tumour suppressor gene proteins in oesophageal cancer. Indian J. Exp. Biol.36(6), 559–563 (1998).
   PubMedGoogle Scholar
• Koutsky L. Epidemiology of genital human papillomavirus infection. Am. J. Med.102(5A), 3–8 (1997).
   PubMedGoogle Scholar
• Das BC, Hussain S, Nasare V, Bharadwaj M. Prospects and prejudices of human papillomavirus vaccines in India. Vaccine26(22), 2669–2679 (2008).
   PubMed Web of Science ®Google Scholar
• Ho GY, Burk RD, Klein S et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J. Natl Cancer Inst.87(18), 1365–1371 (1995).
   PubMed Web of Science ®Google Scholar
• Smith JS, Lindsay L, Hoots B et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int. J. Cancer121(3), 621–632 (2007).
   PubMed Web of Science ®Google Scholar
• Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine24(Suppl. 3), 1–10 (2006).
   Web of Science ®Google Scholar
• Mbulawa ZZ, Coetzee D, Marais DJ et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J. Infect. Dis.199(10), 1514–1524 (2009).
   PubMedGoogle Scholar
• Burchell AN, Winer RL, de Sanjose S, Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine24(Suppl. 3), 52–61 (2006).
   Web of Science ®Google Scholar
• Das BC, Sehgal A, Murthy NS et al. Human papillomavirus and cervical cancer in Indian women. Lancet2(8674), 1271 (1989).
   PubMedGoogle Scholar
• Murthy NS, Sehgal A, Satyanarayana L et al. Risk factors related to biological behaviour of precancerous lesions of the uterine cervix. Br. J. Cancer61(5), 732–736 (1990).
   PubMed Web of Science ®Google Scholar
• Castellsague X, Bosch FX, Munoz N et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N. Engl. J. Med.346(15), 1105–1112 (2002).
   PubMed Web of Science ®Google Scholar
• Van Howe RS. Human papillomavirus and circumcision: a meta-analysis. J. Infect.54(5), 490–496 (2007).
   PubMedGoogle Scholar
• Tobian AA, Serwadda D, Quinn TC et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N. Engl. J. Med.360(13), 1298–1309 (2009).
   PubMed Web of Science ®Google Scholar
• Nandakumar A, Ramnath T, Chaturvedi M. The magnitude of cancer cervix in India. Indian J. Med. Res.130(3), 219–221 (2009).
   PubMed Web of Science ®Google Scholar
• Bhatla N, Lal N, Bao YP, Ng T, Qiao YL. A meta-analysis of human papillomavirus type-distribution in women from South Asia: implications for vaccination. Vaccine26(23), 2811–2817 (2008).
   PubMedGoogle Scholar
• Das BC, Gopalkrishna V, Das DK et al. Human papillomavirus DNA sequences in adenocarcinoma of the uterine cervix in Indian women. Cancer72(1), 147–153 (1993).
   PubMedGoogle Scholar
• Iwasawa A, Nieminen P, Lehtinen M, Paavonen J. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction. Cancer77(11), 2275–2279 (1996).
   PubMed Web of Science ®Google Scholar
• Das BC, Sharma JK, Gopalakrishna V, Luthra UK. Analysis by polymerase chain reaction of the physical state of human papillomavirus type 16 DNA in cervical preneoplastic and neoplastic lesions. J. Gen. Virol.73(Pt 9), 2327–2336 (1992).
   PubMedGoogle Scholar
• Kailash U, Soundararajan CC, Lakshmy R et al. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer. Br. J. Cancer95(9), 1250–1257 (2006).
   PubMed Web of Science ®Google Scholar
• Pande S, Jain N, Prusty BK et al. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J. Clin. Microbiol.46(3), 1060–1066 (2008).
   PubMed Web of Science ®Google Scholar
• Bhatla N, Dar L, Rajkumar Patro A et al. Human papillomavirus-type distribution in women with and without cervical neoplasia in north India. Int. J. Gynecol. Pathol.27(3), 426–430 (2008).
   PubMed Web of Science ®Google Scholar
• Bhatla N, Dar L, Patro AR et al. Human papillomavirus type distribution in cervical cancer in Delhi, India. Int. J. Gynecol. Pathol.25(4), 398–402 (2006).
   PubMedGoogle Scholar
• Franceschi S, Rajkumar T, Vaccarella S et al. Human papillomavirus and risk factors for cervical cancer in Chennai, India: a case–control study. Int. J. Cancer107(1), 127–133 (2003).
   PubMed Web of Science ®Google Scholar
• Sowjanya AP, Jain M, Poli UR et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect. Dis.5, 116 (2005).
   PubMedGoogle Scholar
• Gopalkrishna V, Hedau S, Kailash U, Das BC. Human papillomavirus type 16 in cancer of the uterine cervix in different geographical regions of India (PS011). Presented at: 18th International Papillomavirus Conference. Barcelona, Spain, 23–28 July 2000.
   Google Scholar
• Anwar K, Inuzuka M, Shiraishi T, Nakakuki K. Detection of HPV DNA in neoplastic and non-neoplastic cervical specimens from Pakistan and Japan by non-isotopic in situ hybridization. Int. J. Cancer47(5), 675–680 (1991).
   PubMed Web of Science ®Google Scholar
• Bhurgri Y. Karachi Cancer Registry Data – implications for the National Cancer Control Program of Pakistan. Asian Pac. J. Cancer Prev.5(1), 77–82 (2004).
   PubMedGoogle Scholar
• Bhurgri Y, Bhurgri A, Rahim A et al. The pattern of malignancies in Karachi (1995 to 1996). J. Pak. Med. Assoc.49(7), 157–161 (1999).
   PubMedGoogle Scholar
• Jamal S, Moghal S, Mamoon N et al. The pattern of malignant tumours: tumour registry data analysis, AFIP, Rawalpindi, Pakistan (1992–2001). J. Pak. Med. Assoc.56(8), 359–362 (2006).
   PubMedGoogle Scholar
• Prusty BK, Kumar A, Arora R, Batra S, Das BC. Human papillomavirus (HPV) DNA detection in self-collected urine. Int. J. Gynaecol. Obstet.90(3), 223–227 (2005).
   PubMedGoogle Scholar
• Laikangbam P, Sengupta S, Bhattacharya P et al. A comparative profile of the prevalence and age distribution of human papillomavirus type 16/18 infections among three states of India with focus on northeast India. Int. J. Gynecol. Cancer17(1), 107–117 (2007).
   PubMedGoogle Scholar
• Franceschi S, Herrero R, Clifford GM et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. Int. J. Cancer119(11), 2677–2684 (2006).
   PubMed Web of Science ®Google Scholar
• Winer RL, Hughes JP, Feng Q et al. Condom use and the risk of genital human papillomavirus infection in young women. N. Engl. J. Med.354(25), 2645–2654 (2006).
   PubMed Web of Science ®Google Scholar
• Harper DM, Franco EL, Wheeler C et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet364(9447), 1757–1765 (2004).
   PubMed Web of Science ®Google Scholar
• Villa LL, Costa RL, Petta CA et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre Phase II efficacy trial. Lancet Oncol.6(5), 271–278 (2005).
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep.56(RR-2), 1–24 (2007).
   PubMedGoogle Scholar
• Garland SM. Can cervical cancer be eradicated by prophylactic HPV vaccination? Challenges to vaccine implementation. Indian J. Med. Res.130(3), 311–321 (2009).
   PubMedGoogle Scholar
• Wheeler CM, Kjaer SK, Sigurdsson K et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16–26 years. J. Infect. Dis.199(7), 936–944 (2009).
   PubMed Web of Science ®Google Scholar
• Bayas JM, Costas L, Munoz A. Cervical cancer vaccination indications, efficacy, and side effects. Gynecol. Oncol.110(3 Suppl. 2), S11–S14 (2008).
   Google Scholar
• Arora R, Kumar A, Prusty BK et al. Prevalence of high-risk human papillomavirus (HR-HPV) types 16 and 18 in healthy women with cytologically negative Pap smear. Eur. J. Obstet. Gynecol. Reprod. Biol.121(1), 104–109 (2005).
   PubMedGoogle Scholar
• Munoz N, Manalastas R Jr, Pitisuttithum P et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial. Lancet373(9679), 1949–1957 (2009).
   PubMed Web of Science ®Google Scholar
• AOGIN-INDIA. AOGIN India Biennial Conference (Interim) Proceedings. In: Asia Oceania Research Organization on Genital Infection & Neoplasia (AOGIN). Basu P (Ed.). Kolkata, India (2009).
   Google Scholar
• Pillai MR, Hariharan R, Babu JM et al. Molecular variants of HPV-16 associated with cervical cancer in Indian population. Int. J. Cancer125(1), 91–103 (2009).
   PubMedGoogle Scholar
• WHO. Global Human Papillomavirus (HPV) Laboratory Network. In: WHO HPV LabNet – Newsletter 01. WHO, Geneva, Switzerland (2007).
   Google Scholar
• Lower Genital Tract Precancer. Colposcopy, Pathology and Treatment. Singer A, Monaghan JM (Eds). Blackwell, Oxford, UK (2000).
   Google Scholar
• Sankaranarayanan R, Nene BM, Shastri SS et al. HPV screening for cervical cancer in rural India. N. Engl. J. Med.360(14), 1385–1394 (2009).
   PubMed Web of Science ®Google Scholar
• Qiao YL, Sellors JW, Eder PS et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol.9(10), 929–936 (2008).
   PubMed Web of Science ®Google Scholar
• Moore KN, Walker JL. High risk human papillomavirus testing: guidelines for use in screening, triage, and follow-up for the prevention and early detection of cervical cancer. J. Natl Compr. Canc. Netw.2(6), 589–596 (2004).
   PubMedGoogle Scholar
• Manos MM, Kinney WK, Hurley LB et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA281(17), 1605–1610 (1999).
   PubMed Web of Science ®Google Scholar
• Ronnett BM, Manos MM, Ransley JE et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum. Pathol.30(7), 816–825 (1999).
   PubMed Web of Science ®Google Scholar
• Hubbard RA. Human papillomavirus testing methods. Arch. Pathol. Lab. Med.127(8), 940–945 (2003).
   PubMed Web of Science ®Google Scholar
• Chen B, Yin H, Dhurandhar N. Detection of human papillomavirus DNA in esophageal squamous cell carcinomas by the polymerase chain reaction using general consensus primers. Hum. Pathol.25(9), 920–923 (1994).
   PubMed Web of Science ®Google Scholar
• Monk BJ, Cook N, Ahn C et al. Comparison of the polymerase chain reaction and Southern blot analysis in detecting and typing human papilloma virus deoxyribonucleic acid in tumors of the lower female genital tract. Diagn. Mol. Pathol.3(4), 283–291 (1994).
   PubMedGoogle Scholar
• Saiki RK, Walsh PS, Levenson CH, Erlich HA. Genetic analysis of amplified DNA with immobilized sequence-specific oligonucleotide probes. Proc. Natl Acad. Sci. USA86(16), 6230–6234 (1989).
   PubMed Web of Science ®Google Scholar
• Schiffman MH, Bauer HM, Lorincz AT et al. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J. Clin. Microbiol.29(3), 573–577 (1991).
   PubMed Web of Science ®Google Scholar
• Laconi S, Greco M, Pellegrini-Bettoli P et al. One-step detection and genotyping of human papillomavirus in cervical samples by reverse hybridization. Diagn. Mol. Pathol.10(3), 200–206 (2001).
   PubMedGoogle Scholar
• Reesink-Peters N, Burger MP, Kleter B et al. Using a new HPV detection system in epidemiological research: change of views on cervical dyskaryosis? Eur. J. Obstet. Gynecol. Reprod. Biol.98(2), 199–204 (2001).
   PubMedGoogle Scholar
• Manos MM, Waldman J, Zhang TY et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J. Infect. Dis.170(5), 1096–1099 (1994).
   PubMedGoogle Scholar
• Perrons C, Kleter B, Jelley R et al. Detection and genotyping of human papillomavirus DNA by SPF10 and MY09/11 primers in cervical cells taken from women attending a colposcopy clinic. J. Med. Virol.67(2), 246–252 (2002).
   PubMedGoogle Scholar
• Coutlee F, Gravitt P, Kornegay J et al. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J. Clin. Microbiol.40(3), 902–907 (2002).
   PubMed Web of Science ®Google Scholar
• Gravitt PE, Peyton CL, Alessi TQ et al. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol.38(1), 357–361 (2000).
   PubMed Web of Science ®Google Scholar
• Das BC, Sharma JK, Gopalkrishna V et al. A high frequency of human papillomavirus DNA sequences in cervical carcinomas of Indian women as revealed by Southern blot hybridization and polymerase chain reaction. J. Med. Virol.36(4), 239–245 (1992).
   PubMedGoogle Scholar
• Durst M, Gissmann L, Ikenberg H, zur Hausen H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA80(12), 3812–3815 (1983).
   PubMed Web of Science ®Google Scholar
• Hallam N, Gibson P, Green J, Charnock M. Detection and typing of human papillomavirus infection of the uterine cervix by dot blot hybridisation: comparison of scrapes and biopsies. J. Med. Virol.27(4), 317–321 (1989).
   PubMedGoogle Scholar
• Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J. Clin. Microbiol.41(7), 3221–3228 (2003).
   PubMedGoogle Scholar
• Feng Q, Cherne S, Winer RL et al. Development and evaluation of a liquid bead microarray assay for genotyping genital human papillomaviruses. J. Clin. Microbiol.47(3), 547–553 (2009).
   PubMedGoogle Scholar
• Schmitt M, Bravo IG, Snijders PJ et al. Bead-based multiplex genotyping of human papillomaviruses. J. Clin. Microbiol.44(2), 504–512 (2006).
   PubMed Web of Science ®Google Scholar
• Kailash U, Hedau S, Gopalkrishna V, Katiyar S, Das BC. A simple ‘paper smear’ method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR. J. Med. Microbiol.51(7), 606–610 (2002).
   PubMedGoogle Scholar
• Das BC, Gopalkrishna V, Sharma JK, Roy M, Luthra UK. Human papillomavirus DNA in urine of women with preneoplastic and neoplastic cervical lesions. Lancet340(8832), 1417–1418 (1992).
   PubMedGoogle Scholar
• Gupta A, Arora R, Gupta S et al. Human papillomavirus DNA in urine samples of women with or without cervical cancer and their male partners compared with simultaneously collected cervical/penile smear or biopsy specimens. J. Clin. Virol.37(3), 190–194 (2006).
   PubMed Web of Science ®Google Scholar
• Wilkinson DE, Baylis SA, Padley D et al. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int. J. Cancer126(12), 2969–2983 (2009).
   Google Scholar
• Shukla S, Bharti AC, Hussain S et al. Elimination of high-risk human papillomavirus type HPV16 infection by ‘Praneem’ polyherbal tablet in women with early cervical intraepithelial lesions. J. Cancer Res. Clin. Oncol.135(12), 1701–1709 (2009).
   PubMed Web of Science ®Google Scholar
• Prusty BK, Das BC. Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int. J. Cancer113(6), 951–960 (2005).
   PubMed Web of Science ®Google Scholar
• Mahata S. Transcriptional control of human papillomavirus oncogene expression by antioxidative agents. In: PhD thesis, Department of Biosciences. Jamia Millia Islamia, New Delhi, India, 190 (2009).
   Google Scholar
• Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD et al. Cost–effectiveness of cervical-cancer screening in five developing countries. N. Engl. J. Med.353(20), 2158–2168 (2005).
   PubMed Web of Science ®Google Scholar